Edition:
India

Livzon Pharmaceutical Announces Capital Contribution Deal For Yizun Biopharmaceutics (Shanghai)


Wednesday, 5 Jun 2019 

June 5 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::ANNOUNCES CAPITAL CONTRIBUTION AGREEMENT IN RELATION TO YIZUN BIOPHARMACEUTICS (SHANGHAI).ZHUHAI KADI MEDICAL BIOTECHNOLOGY TO INVEST RMB30 MILLION FOR ADDITIONAL REGISTERED CAPITAL OF 10 PERCENT OF YIZUN BIOPHARMACEUTICS. 

Company Quote

20.45
-0.3 -1.45%
11:16am IST